Skip to main content
Top
Published in: Langenbeck's Archives of Surgery 4/2007

01-07-2007 | Original Article

Adrenal involvement in multiple endocrine neoplasia type 1: results of 7 years prospective screening

Authors: J. Waldmann, D. K. Bartsch, P. H. Kann, V. Fendrich, M. Rothmund, P. Langer

Published in: Langenbeck's Archives of Surgery | Issue 4/2007

Login to get access

Abstract

Background

Adrenal tumors are a common manifestation of the multiple endocrine neoplasia type 1 (MEN-1) syndrome. Prevalence in recent studies varies between 9 and 45%. A genotype–phenotype correlation has been described as well as the development of adrenocortical carcinomas. Long-term prospective data are still lacking.

Materials and methods

Thirty-eight MEN-1 patients with proven germline mutations have been prospectively observed in a regular screening program in our hospital. Adrenal glands have been screened by biochemical analysis and either by endoscopic ultrasound (EUS) or computed tomography (CT) or both. Median follow-up was 48 months (12–108 months). Age at diagnosis of MEN-1, type of adrenal tumor, genotype, therapy, and clinical characteristics have been analyzed.

Results

In 21 (55%) patients, adrenal involvement of the disease was detected. Adrenal lesions were detected in average 6.9 years after the initial diagnosis of MEN-1. Median tumor size was 12 mm (5–40 mm). Tumor size smaller than 10 mm was observed in 11 patients. Twelve patients had unilateral while nine had bilateral adrenal lesions. EUS detected all adrenal tumors, whereas CT failed in seven cases. In three patients, functioning tumors (one pheochromocytoma, one bilateral Cushing adenoma, and one adrenocortical carcinoma) and one nonfunctioning adenoma were diagnosed by histology and biochemical assessment. Two laparoscopic adrenalectomies and one laparoscopic subtotal resection were performed. Nonfunctioning adrenal lesions, not characterized by histology yet, were found in 18 patients. There was no statistical difference with regard to adrenal involvement between patients with germline mutations in exons 2 and 10 (12/21) and those with mutations in exons 3–9 (6/11).

Conclusion

MEN-1-associated adrenal tumors are mostly small, benign, and nonfunctioning and much more common than previously reported. EUS was the most sensitive imaging procedure. The genotype–pheotype correlation previously suggested by our group could not be confirmed.
Literature
1.
go back to reference Chandrasekharappa SC et al (1997) Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 276(5311):404–407PubMedCrossRef Chandrasekharappa SC et al (1997) Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 276(5311):404–407PubMedCrossRef
2.
3.
go back to reference Burgess JR, Greenaway TM, Shepherd JJ (1998) Expression of the MEN-1 gene in a large kindred with multiple endocrine neoplasia type 1. J Intern Med 243(6):465–470PubMedCrossRef Burgess JR, Greenaway TM, Shepherd JJ (1998) Expression of the MEN-1 gene in a large kindred with multiple endocrine neoplasia type 1. J Intern Med 243(6):465–470PubMedCrossRef
4.
go back to reference Darling TN et al (1997) Multiple facial angiofibromas and collagenomas in patients with multiple endocrine neoplasia type 1. Arch Dermatol 133(7):853–857PubMedCrossRef Darling TN et al (1997) Multiple facial angiofibromas and collagenomas in patients with multiple endocrine neoplasia type 1. Arch Dermatol 133(7):853–857PubMedCrossRef
5.
go back to reference Duh QY et al (1987) Carcinoids associated with multiple endocrine neoplasia syndromes. Am J Surg 154(1):142–148PubMedCrossRef Duh QY et al (1987) Carcinoids associated with multiple endocrine neoplasia syndromes. Am J Surg 154(1):142–148PubMedCrossRef
6.
go back to reference Gibril F et al (2003) Prospective study of thymic carcinoids in patients with multiple endocrine neoplasia type 1. J Clin Endocrinol Metab 88(3):1066–1081PubMedCrossRef Gibril F et al (2003) Prospective study of thymic carcinoids in patients with multiple endocrine neoplasia type 1. J Clin Endocrinol Metab 88(3):1066–1081PubMedCrossRef
7.
go back to reference Hofmann M et al (1998) Multiple endocrine neoplasia associated with multiple lipomas. Med Klin (Munich) 93(9):546–549CrossRef Hofmann M et al (1998) Multiple endocrine neoplasia associated with multiple lipomas. Med Klin (Munich) 93(9):546–549CrossRef
8.
go back to reference Marx S et al (1998) Multiple endocrine neoplasia type 1: clinical and genetic topics. Ann Intern Med 129(6):484–494PubMed Marx S et al (1998) Multiple endocrine neoplasia type 1: clinical and genetic topics. Ann Intern Med 129(6):484–494PubMed
9.
go back to reference Lips CJ, Vasen HF, Lamers CB (1984) Multiple endocrine neoplasia syndromes. Crit Rev Oncol Hematol 2(2):117–184PubMed Lips CJ, Vasen HF, Lamers CB (1984) Multiple endocrine neoplasia syndromes. Crit Rev Oncol Hematol 2(2):117–184PubMed
10.
go back to reference Thakker RV (2000) Multiple endocrine neoplasia type 1. Endocrinol Metab Clin North Am 29(3):541–567PubMedCrossRef Thakker RV (2000) Multiple endocrine neoplasia type 1. Endocrinol Metab Clin North Am 29(3):541–567PubMedCrossRef
11.
go back to reference Carty SE et al (1998) The variable penetrance and spectrum of manifestations of multiple endocrine neoplasia type 1. Surgery 124(6):1106–1113; discussion 1113–4PubMedCrossRef Carty SE et al (1998) The variable penetrance and spectrum of manifestations of multiple endocrine neoplasia type 1. Surgery 124(6):1106–1113; discussion 1113–4PubMedCrossRef
12.
go back to reference Skogseid B et al (1992) Clinical and genetic features of adrenocortical lesions in multiple endocrine neoplasia type 1. J Clin Endocrinol Metab 75(1):76–81PubMedCrossRef Skogseid B et al (1992) Clinical and genetic features of adrenocortical lesions in multiple endocrine neoplasia type 1. J Clin Endocrinol Metab 75(1):76–81PubMedCrossRef
13.
go back to reference Skogseid B et al (1995) Adrenal lesion in multiple endocrine neoplasia type 1. Surgery 118(6):1077–1082PubMedCrossRef Skogseid B et al (1995) Adrenal lesion in multiple endocrine neoplasia type 1. Surgery 118(6):1077–1082PubMedCrossRef
14.
go back to reference Burgess JR et al (1996) Adrenal lesions in a large kindred with multiple endocrine neoplasia type 1. Arch Surg 131(7):699–702PubMed Burgess JR et al (1996) Adrenal lesions in a large kindred with multiple endocrine neoplasia type 1. Arch Surg 131(7):699–702PubMed
15.
go back to reference Langer P et al (2002) Adrenal involvement in multiple endocrine neoplasia type 1. World J Surg 26(8):891–896PubMedCrossRef Langer P et al (2002) Adrenal involvement in multiple endocrine neoplasia type 1. World J Surg 26(8):891–896PubMedCrossRef
16.
go back to reference Barzon L et al (2001) Multiple endocrine neoplasia type 1 and adrenal lesions. J Urol 166(1):24–27PubMedCrossRef Barzon L et al (2001) Multiple endocrine neoplasia type 1 and adrenal lesions. J Urol 166(1):24–27PubMedCrossRef
17.
go back to reference Gibril F et al (2004) Multiple endocrine neoplasia type 1 and Zollinger–Ellison syndrome: a prospective study of 107 cases and comparison with 1009 cases from the literature. Medicine (Baltimore) 83(1):43–83CrossRef Gibril F et al (2004) Multiple endocrine neoplasia type 1 and Zollinger–Ellison syndrome: a prospective study of 107 cases and comparison with 1009 cases from the literature. Medicine (Baltimore) 83(1):43–83CrossRef
18.
go back to reference Cadiot G et al (1999) Prognostic factors in patients with Zollinger–Ellison syndrome and multiple endocrine neoplasia type 1. Groupe d’Etude des Neoplasies Endocriniennes Multiples (GENEM and groupe de Recherche et d’Etude du Syndrome de Zollinger–Ellison (GRESZE). Gastroenterology 116(2):286–293PubMedCrossRef Cadiot G et al (1999) Prognostic factors in patients with Zollinger–Ellison syndrome and multiple endocrine neoplasia type 1. Groupe d’Etude des Neoplasies Endocriniennes Multiples (GENEM and groupe de Recherche et d’Etude du Syndrome de Zollinger–Ellison (GRESZE). Gastroenterology 116(2):286–293PubMedCrossRef
19.
go back to reference Ballard HS, Fame B, Hartstock RJ (1964) Familial endocrine adenoma-peptic ulcer complex. Medicine (Baltimore) 43:481–516CrossRef Ballard HS, Fame B, Hartstock RJ (1964) Familial endocrine adenoma-peptic ulcer complex. Medicine (Baltimore) 43:481–516CrossRef
20.
go back to reference Croisier JC, Azerad E, Lubetzki J (1971) L’adenomatose polyendocrinienne (syndrome de Wermer). Semin Hop Paris 47:494–525 Croisier JC, Azerad E, Lubetzki J (1971) L’adenomatose polyendocrinienne (syndrome de Wermer). Semin Hop Paris 47:494–525
21.
22.
23.
go back to reference Hedeland H, Ostberg G, Hokfelt B (1968) On the prevalence of adrenocortical adenomas in an autopsy material in relation to hypertension and diabetes. Acta Med Scand 184(3):211–214PubMed Hedeland H, Ostberg G, Hokfelt B (1968) On the prevalence of adrenocortical adenomas in an autopsy material in relation to hypertension and diabetes. Acta Med Scand 184(3):211–214PubMed
24.
go back to reference Anonymous (2002) NIH state-of-the-science statement on management of the clinically inapparent adrenal mass (“incidentaloma”). NIH Consens State Sci Statements 19(2):1–25 Anonymous (2002) NIH state-of-the-science statement on management of the clinically inapparent adrenal mass (“incidentaloma”). NIH Consens State Sci Statements 19(2):1–25
25.
go back to reference Thompson GB, Young WF Jr (2003) Adrenal incidentaloma. Curr Opin Oncol 15(1):84–90CrossRef Thompson GB, Young WF Jr (2003) Adrenal incidentaloma. Curr Opin Oncol 15(1):84–90CrossRef
26.
go back to reference Kloos RT et al (1997) Diagnostic dilemma of small incidentally discovered adrenal masses: role for 131I-6beta-iodomethyl-norcholesterol scintigraphy. World J Surg 21(1):36–40PubMedCrossRef Kloos RT et al (1997) Diagnostic dilemma of small incidentally discovered adrenal masses: role for 131I-6beta-iodomethyl-norcholesterol scintigraphy. World J Surg 21(1):36–40PubMedCrossRef
27.
go back to reference Commons RR, Callaway CP (1948) Adenomas of the adrenal cortex. Arch Intern Med 81:37–41 Commons RR, Callaway CP (1948) Adenomas of the adrenal cortex. Arch Intern Med 81:37–41
28.
go back to reference Reinhard C, Saeger W, Schubert B (1996) Adrenocortical nodules in post-mortem series. Development, functional significance, and differentiation from adenomas. Gen Diagn Pathol 141(3–4):203–208PubMed Reinhard C, Saeger W, Schubert B (1996) Adrenocortical nodules in post-mortem series. Development, functional significance, and differentiation from adenomas. Gen Diagn Pathol 141(3–4):203–208PubMed
29.
go back to reference Granger P, Genest J (1970) Autopsy study of adrenals in unselected normotensive and hypertensive patients. Can Med Assoc J 103(1):34–36PubMed Granger P, Genest J (1970) Autopsy study of adrenals in unselected normotensive and hypertensive patients. Can Med Assoc J 103(1):34–36PubMed
30.
go back to reference Brandi ML et al (2001) Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 86(12):5658–5671PubMedCrossRef Brandi ML et al (2001) Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 86(12):5658–5671PubMedCrossRef
31.
go back to reference Skogseid B et al (1996) Surgery for asymptomatic pancreatic lesion in multiple endocrine neoplasia type I. World J Surg 20(7):872–876; discussion 877PubMedCrossRef Skogseid B et al (1996) Surgery for asymptomatic pancreatic lesion in multiple endocrine neoplasia type I. World J Surg 20(7):872–876; discussion 877PubMedCrossRef
32.
go back to reference Brandi ML et al (1987) Familial multiple endocrine neoplasia type I: a new look at pathophysiology. Endocr Rev 8(4):391–405PubMedCrossRef Brandi ML et al (1987) Familial multiple endocrine neoplasia type I: a new look at pathophysiology. Endocr Rev 8(4):391–405PubMedCrossRef
33.
go back to reference Trump D et al (1996) Clinical studies of multiple endocrine neoplasia type 1 (MEN1). Q J Med 89(9):653–669 Trump D et al (1996) Clinical studies of multiple endocrine neoplasia type 1 (MEN1). Q J Med 89(9):653–669
34.
go back to reference Chico A et al (2000) Genetic, clinical, and biochemical analysis of unrelated Spanish families with multiple endocrine neoplasia type I. Endocr Pract 6(1):13–19PubMed Chico A et al (2000) Genetic, clinical, and biochemical analysis of unrelated Spanish families with multiple endocrine neoplasia type I. Endocr Pract 6(1):13–19PubMed
35.
go back to reference Agarwal SK et al (1999) Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription. Cell 96(1):143–152PubMedCrossRef Agarwal SK et al (1999) Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription. Cell 96(1):143–152PubMedCrossRef
36.
go back to reference Kim YS et al (1999) Stable overexpression of MEN1 suppresses tumorigenicity of RAS. Oncogene 18(43):5936–5942PubMedCrossRef Kim YS et al (1999) Stable overexpression of MEN1 suppresses tumorigenicity of RAS. Oncogene 18(43):5936–5942PubMedCrossRef
37.
go back to reference Heppner C et al (2001) The tumor suppressor protein menin interacts with NF-kappaB proteins and inhibits NF-kappaB-mediated transactivation. Oncogene 20(36):4917–4925PubMedCrossRef Heppner C et al (2001) The tumor suppressor protein menin interacts with NF-kappaB proteins and inhibits NF-kappaB-mediated transactivation. Oncogene 20(36):4917–4925PubMedCrossRef
38.
go back to reference Zwermann O et al (2000) Multiple endocrine neoplasia type 1 gene expression is normal in sporadic adrenocortical tumors. Eur J Endocrinol 142(6):689–695PubMedCrossRef Zwermann O et al (2000) Multiple endocrine neoplasia type 1 gene expression is normal in sporadic adrenocortical tumors. Eur J Endocrinol 142(6):689–695PubMedCrossRef
39.
go back to reference Schulte KM et al (1999) MEN I gene mutations in sporadic adrenal adenomas. Hum Genet 105(6):603–610PubMedCrossRef Schulte KM et al (1999) MEN I gene mutations in sporadic adrenal adenomas. Hum Genet 105(6):603–610PubMedCrossRef
40.
go back to reference Gortz B et al (1999) MEN1 gene mutation analysis of sporadic adrenocortical lesions. Int J Cancer 80(3):373–379PubMedCrossRef Gortz B et al (1999) MEN1 gene mutation analysis of sporadic adrenocortical lesions. Int J Cancer 80(3):373–379PubMedCrossRef
41.
go back to reference Heppner C et al (1999) MEN1 gene analysis in sporadic adrenocortical neoplasms. J Clin Endocrinol Metab 84(1):216–219PubMedCrossRef Heppner C et al (1999) MEN1 gene analysis in sporadic adrenocortical neoplasms. J Clin Endocrinol Metab 84(1):216–219PubMedCrossRef
42.
go back to reference Crabtree JS et al (2001) A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors. Proc Natl Acad Sci USA 98(3):1118–1123PubMedCrossRef Crabtree JS et al (2001) A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors. Proc Natl Acad Sci USA 98(3):1118–1123PubMedCrossRef
43.
go back to reference Tomassetti P et al (1995) Chromosomal instability in multiple endocrine neoplasia type 1. Cytogenetic evaluation with DEB test. Cancer Genet Cytogenet 79(2):123–126PubMedCrossRef Tomassetti P et al (1995) Chromosomal instability in multiple endocrine neoplasia type 1. Cytogenetic evaluation with DEB test. Cancer Genet Cytogenet 79(2):123–126PubMedCrossRef
44.
go back to reference Scappaticci S et al (1992) Cytogenetics of multiple endocrine neoplasia syndrome. II. Chromosome abnormalities in an insulinoma and a glucagonoma from two subjects with MEN1. Cancer Genet Cytogenet 63(1):17–21PubMedCrossRef Scappaticci S et al (1992) Cytogenetics of multiple endocrine neoplasia syndrome. II. Chromosome abnormalities in an insulinoma and a glucagonoma from two subjects with MEN1. Cancer Genet Cytogenet 63(1):17–21PubMedCrossRef
45.
go back to reference Pannett AA, Thakker RV (2001) Somatic mutations in MEN type 1 tumors, consistent with the Knudson “two-hit” hypothesis. J Clin Endocrinol Metab 86(9):4371–4374PubMedCrossRef Pannett AA, Thakker RV (2001) Somatic mutations in MEN type 1 tumors, consistent with the Knudson “two-hit” hypothesis. J Clin Endocrinol Metab 86(9):4371–4374PubMedCrossRef
46.
go back to reference Bartsch DK et al (2000) Pancreaticoduodenal endocrine tumors in multiple endocrine neoplasia type 1: surgery or surveillance? Surgery 128(6):958–966PubMedCrossRef Bartsch DK et al (2000) Pancreaticoduodenal endocrine tumors in multiple endocrine neoplasia type 1: surgery or surveillance? Surgery 128(6):958–966PubMedCrossRef
Metadata
Title
Adrenal involvement in multiple endocrine neoplasia type 1: results of 7 years prospective screening
Authors
J. Waldmann
D. K. Bartsch
P. H. Kann
V. Fendrich
M. Rothmund
P. Langer
Publication date
01-07-2007
Publisher
Springer-Verlag
Published in
Langenbeck's Archives of Surgery / Issue 4/2007
Print ISSN: 1435-2443
Electronic ISSN: 1435-2451
DOI
https://doi.org/10.1007/s00423-006-0124-7

Other articles of this Issue 4/2007

Langenbeck's Archives of Surgery 4/2007 Go to the issue